Key result
ACE inhibitors and angiotensin II receptor antagonists exhibit clear dose-response relationships when evaluated in normal volunteers based on their designed mechanisms.
Characterizing dose-response curves of ACE inhibitors and ARBs in normal volunteers is important for determining optimal dosing and achieving maximal therapeutic benefit.
Answers are grounded in this paper and cite their sources.
Normal volunteer dose-response data may inform initial titration; leaves open validation and optimization in patients with cardiovascular disease.
It is difficult to establish dose-response relationships for ACE inhibitors in patients with hypertension or congestive heart failure. This has led to the widely held opinion that the effects of ACE inhibitors are hardly dose dependent. The purpose of this short discussion is to demonstrate that this class of compounds, as well as the more recent angiotensin II receptor antagonists, exhibit some very clear dose-response relationships when these are evaluated in normal volunteers based on the mechanisms for which they were designed. Characterization of these dose-response curves is important in order to use these drugs at their optimal dose and to obtain the maximal therapeutic benefit.
No takes yet. Share an insight, caveat, or question.
Brunner et al. (1994) conducted a review in Hypertension or congestive heart failure. ACE inhibitors and Angiotensin II receptor antagonists was evaluated. ACE inhibitors and angiotensin II receptor antagonists exhibit clear dose-response relationships when evaluated in normal volunteers based on their designed mechanisms.
Synapse has enriched 10 related papers. Consider them for comparative context: